R

ReShape Lifesciences
D

RSLS

5.71000
USD
0.30
(5.55%)
Market Closed
Volume
1,183
EPS
-17
Div Yield
-
P/E
0
Market Cap
4,069,403
OverviewSignalsIdeasNews
Related Instruments
    A
    ANY
    0.02000
    (1.37%)
    1.48000 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    I
    INUV
    0.00380
    (1.89%)
    0.20460 USD
    I
    IZEA
    0.01000
    (0.35%)
    2.87000 USD
    S
    SINT
    -0.16000
    (-7.27%)
    2.04000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: ReShape Lifesciences Inc

Sector: Healthcare
Industry: Medical Devices
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.